Related Experiment Video
Updated: Nov 16, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Solving Unmet Needs With Innovative Pediatric Medical Devices
Insights
Few life-saving medical devices are approved for pediatric patients, especially infants and neonates. Adult devices are often modified, but these solutions may not meet children
Area of Science:
- Biomedical Engineering
- Pediatric Medicine
- Regulatory Science
Background:
- Class III life-saving devices approved by the U.S. Food and Drug Administration (FDA) are rarely designated for pediatric use, with only 24% approved in the last decade.
- The majority of approved pediatric devices are for older children (over 12 years), with less than 4% specifically labeled for infants and toddlers (0-2 years).
- Neonatal patients face an even greater scarcity of approved medical devices.
Purpose of the Study:
- To highlight the critical gap in life-saving medical device availability for pediatric and neonatal populations.
- To underscore the challenges and limitations of using repurposed adult devices for young patients.
- To advocate for the development of novel medical devices tailored to the unique physiological needs of children.
Main Methods:
- Analysis of FDA approval data for Class III life-saving medical devices over the past decade.
- Categorization of approved devices based on patient age group (pediatric vs. adult, and sub-categories within pediatrics).
- Review of current clinical practices involving the adaptation of adult devices for pediatric use.
Main Results:
- A significant underrepresentation of pediatric-use medical devices among FDA-approved Class III devices.
- A pronounced lack of devices specifically designed and approved for the youngest pediatric age groups (0-2 years) and neonates.
- Prevalence of the use of modified adult medical devices as a workaround for pediatric and neonatal care.
Conclusions:
- There is an urgent unmet need for FDA-approved, life-saving medical devices specifically designed for pediatric and neonatal patients.
- Repurposing adult devices presents significant limitations and potential risks due to differences in anatomy, physiology, and growth patterns.
- Further research and development are crucial to create innovative medical technologies that address the unique requirements of young patients.
Abstract:
In the last decade, only 24% of class III life-saving devices approved by the U.S. Food and Drug Administration (FDA) were for pediatric use-and most of those were for children over 12. Of these, less than 4% were labeled for pediatric patients ages 0-2 years old and the number of approved devices is even lower for neonatal patients. For these young patients, adult medical devices are often manipulated by pediatric specialists in order to provide stop-gap solutions. However, these repurposed devices are not always able to fulfill the unique needs of children's biology and growth patterns.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution

